Caveolin-1 (Cav1) plays a complex role in cancer progression and has been ascribed both tumor promoter and suppressor functions; elevated Cav1 is associated with a poor prognosis in prostate, melanoma cancers and triple negative breast cancer [1, 2]. The gene discussed is CAV1; the disease is triple-negative breast carcinoma.